Literature DB >> 28657340

ICRP Publication 134: Occupational Intakes of Radionuclides: Part 2.

F Paquet, M R Bailey, R W Leggett, J Lipsztein, T P Fell, T Smith, D Nosske, K F Eckerman, V Berkovski, E Ansoborlo, A Giussani, W E Bolch, J D Harrison.   

Abstract

Abstract –: The 2007 Recommendations of the International Commission on Radiological Protection (ICRP, 2007) introduced changes that affect the calculation of effective dose, and implied a revision of the dose coefficients for internal exposure, published previously in the Publication 30 series (ICRP, 1979, 1980, 1981, 1988b) and Publication 68 (ICRP, 1994b). In addition, new data are available that support an update of the radionuclide-specific information given in Publications 54 and 78 (ICRP, 1988a, 1997b) for the design of monitoring programmes and retrospective assessment of occupational internal doses. Provision of new biokinetic models, dose coefficients, monitoring methods, and bioassay data was performed by Committee 2, Task Group 21 on Internal Dosimetry, and Task Group 4 on Dose Calculations. A new series, the Occupational Intakes of Radionuclides (OIR) series, will replace the Publication 30 series and Publications 54, 68, and 78. Part 1 of the OIR series has been issued (ICRP, 2015), and describes the assessment of internal occupational exposure to radionuclides, biokinetic and dosimetric models, methods of individual and workplace monitoring, and general aspects of retrospective dose assessment. The following publications in the OIR series (Parts 2–5) will provide data on individual elements and their radioisotopes, including information on chemical forms encountered in the workplace; a list of principal radioisotopes and their physical half-lives and decay modes; the parameter values of the reference biokinetic model; and data on monitoring techniques for the radioisotopes encountered most commonly in workplaces. Reviews of data on inhalation, ingestion, and systemic biokinetics are also provided for most of the elements. Dosimetric data provided in the printed publications of the OIR series include tables of committed effective dose per intake (Sv per Bq intake) for inhalation and ingestion, tables of committed effective dose per content (Sv per Bq measurement) for inhalation, and graphs of retention and excretion data per Bq intake for inhalation. These data are provided for all absorption types and for the most common isotope(s) of each element. The electronic annex that accompanies the OIR series of reports contains a comprehensive set of committed effective and equivalent dose coefficients, committed effective dose per content functions, and reference bioassay functions. Data are provided for inhalation, ingestion, and direct input to blood. The present publication provides the above data for the following elements: hydrogen (H), carbon (C), phosphorus (P), sulphur (S), calcium (Ca), iron (Fe), cobalt (Co), zinc (Zn), strontium (Sr), yttrium (Y), zirconium (Zr), niobium (Nb), molybdenum (Mo), and technetium (Tc).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28657340     DOI: 10.1177/0146645316670045

Source DB:  PubMed          Journal:  Ann ICRP        ISSN: 0146-6453


  10 in total

1.  Efficient parameter estimation in multiresponse models measuring radioactivity retention.

Authors:  J M Rodríguez-Díaz; G Sánchez-León
Journal:  Radiat Environ Biophys       Date:  2019-02-25       Impact factor: 1.925

2.  Nuclear medicine: workplace monitoring and internal occupational exposure during a ventilation/perfusion single-photon emission tomography.

Authors:  J Martínez; T Baciu; M Artigues; M Danús; A Peñalver; C Aguilar; F Borrull
Journal:  Radiat Environ Biophys       Date:  2019-05-28       Impact factor: 1.925

3.  A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model.

Authors:  Alexander P Klapproth; Maxim Shevtsov; Stefan Stangl; Wei Bo Li; Gabriele Multhoff
Journal:  Int J Nanomedicine       Date:  2020-06-30

4.  Specific Absorbed Fractions for Spontaneous Fission Neutron Emitters in the ICRP Reference Pediatric Voxel Phantom Series.

Authors:  Keith T Griffin; Keith F Eckerman; Ryan P Manger; Derek W Jokisch; Wesley E Bolch; Nolan E Hertel
Journal:  Health Phys       Date:  2022-07-15       Impact factor: 2.922

5.  IDAC-Bio, A Software for Internal Dosimetry Based on the New ICRP Biokinetic Models and Specific Absorbed Fractions.

Authors:  Martin Andersson; Richard W Leggett; Keith Eckerman; Anja Almén; Sören Mattsson
Journal:  Health Phys       Date:  2022-05-20       Impact factor: 2.922

6.  Nanotechnology for the treatment of deep endometriosis: uptake of lipid core nanoparticles by LDL receptors in endometriotic foci.

Authors:  Alessandra Bedin; Raul C Maranhão; Elaine R Tavares; Priscila O Carvalho; Edmund C Baracat; Sérgio Podgaec
Journal:  Clinics (Sao Paulo)       Date:  2019-07-10       Impact factor: 2.365

7.  Internal dose assessment of 148Gd using isotope ratios of gamma-emitting 146Gd or 153Gd in accidently released spallation target particles.

Authors:  C Rääf; V Barkauskas; K Eriksson Stenström; C Bernhardsson; H B L Pettersson
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

Review 8.  Areas of research to support the system of radiological protection.

Authors:  D Laurier; W Rühm; F Paquet; K Applegate; D Cool; C Clement
Journal:  Radiat Environ Biophys       Date:  2021-10-17       Impact factor: 1.925

Review 9.  Radionuclides for Targeted Therapy: Physical Properties.

Authors:  Caroline Stokke; Monika Kvassheim; Johan Blakkisrud
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927

Review 10.  Health effects triggered by tritium: how do we get public understanding based on scientifically supported evidence?

Authors:  Hideki Matsumoto; Yoshiya Shimada; Asako J Nakamura; Noriko Usami; Mitsuaki Ojima; Shizuko Kakinuma; Mikio Shimada; Masaaki Sunaoshi; Ryoichi Hirayama; Hiroshi Tauchi
Journal:  J Radiat Res       Date:  2021-07-10       Impact factor: 2.724

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.